Bal Pharma Ltd.

BSE: 524824 | NSE: BALPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE083D01012 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Bal Pharma Ltd Bal Pharma Ltd. | BSE 73.59 0.34 (0.46%) | NSE 73.02 -0.30 (-0.41%) | Trade | Add

BSE Live

Jan 01, 16:01

73.59 0.34 (0.46%)

Volume

AVERAGE VOLUME

5-Day

4,268

10-Day

2,306

30-Day

1,771

Prev. Close

73.25
Open Price

72.11

Bid Price (Qty.)
72.30 (1)
Offer Price (Qty.)
76.49 (50)

NSE Live

Jan 01, 15:41

73.02 -0.30 (-0.41%)

Volume

AVERAGE VOLUME

5-Day

8,619

10-Day

6,517

30-Day

7,954

2,557

Prev. Close

73.32
Open Price

71.50

Bid Price (Qty.)
73.02 (10)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Bal Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	12.87	11.11	10.57	10.57	10.48
Total Share Capital	12.87	11.11	10.57	10.57	10.48
Reserves and Surplus	40.71	37.20	32.84	29.48	26.02
Total Reserves and Surplus	40.71	37.20	32.84	29.48	26.02
Total Shareholders Funds	55.60	50.05	44.62	40.06	36.51
NON-CURRENT LIABILITIES
Long Term Borrowings	6.64	7.97	1.67	6.09	11.79
Deferred Tax Liabilities [Net]	7.29	8.24	8.24	7.42	6.76
Other Long Term Liabilities	0.75	0.66	1.81	0.64	0.68
Long Term Provisions	1.65	1.06	0.83	0.64	1.00
Total Non-Current Liabilities	16.33	17.92	12.55	14.79	20.23
CURRENT LIABILITIES
Short Term Borrowings	40.14	42.75	44.36	44.53	41.25
Trade Payables	38.49	33.53	32.06	26.92	26.21
Other Current Liabilities	11.77	8.66	14.97	13.96	10.74
Short Term Provisions	1.83	1.83	1.28	0.91	0.47
Total Current Liabilities	92.22	86.77	92.67	86.32	78.68
Total Capital And Liabilities	164.15	154.74	149.84	141.16	135.42
ASSETS
NON-CURRENT ASSETS
Tangible Assets	47.04	50.31	46.74	47.25	47.98
Intangible Assets	4.87	4.87	5.09	5.64	5.95
Capital Work-In-Progress	0.77	0.25	0.87	0.41	0.13
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	52.67	55.42	52.70	53.31	54.05
Non-Current Investments	1.10	0.02	0.02	0.02	0.06
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	5.40	3.96	3.83	3.18	2.18
Other Non-Current Assets	0.33	0.22	0.07	0.16	0.05
Total Non-Current Assets	59.50	59.63	56.62	56.67	56.34
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	35.77	31.71	33.69	33.66	32.21
Trade Receivables	44.99	45.49	43.50	38.19	37.02
Cash And Cash Equivalents	4.54	3.02	4.73	3.03	1.97
Short Term Loans And Advances	19.15	14.76	11.05	9.31	7.77
OtherCurrentAssets	0.20	0.13	0.25	0.31	0.11
Total Current Assets	104.65	95.12	93.21	84.50	79.08
Total Assets	164.15	154.74	149.84	141.16	135.42
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	20.90	18.50	13.30	15.69	12.32
CIF VALUE OF IMPORTS
Raw Materials	41.13	37.92	30.13	28.19	23.53
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.27	0.66	0.03	0.03	0.28
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	1.84	2.03	1.29	1.11	0.85
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	117.13	103.05	82.29	71.42	63.32
Other Earnings	--	--	--	--	--
BONUS DETAILS
Bonus Equity Share Capital	3.04	3.04	3.04	3.04	3.04
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	1.10	0.02	0.02	0.02	0.06
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--